Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	MPOS	POSD
1	NRAS(0.1%)	exon3,c.182A>T,p.Q61L	0.001083	0.0008753	4400|6	1424|2	0.00280	14606|41	1	115256529	115256529	T	A	base_qual,clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenal_cortex_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Gastric_adenocarcinoma|Thyroid_tumor|Nasopharyngeal_neoplasm|Neoplasm_of_the_large_intestine|Ovarian_serous_cystadenocarcinoma|Glioblastoma|Malignant_neoplasm_of_body_of_uterus		25	0.0
	NTRK1(34.5%)	exon14,c.1749C>A,p.R583=	0.345	0.143	38|23	9|0	0.38462	40|25	1	156846308	156846308	C	A	PASS	NTRK1	NM_002529.4	14	c.1749C>A	p.Arg583=	synonymous_variant					39	0.0
	FMN2(26.0%)	exon5,c.2822_2854del,p.G941_A951del	0.26	0.101	40|11	6|0	0.24138	22|7	1	240370913	240370946	TGCCCCCTCTACCCGGAGCGGGAATACCTCCTCC	T	germline,distinguished	FMN2	NM_020066.5	5	c.2822_2854del	p.Gly941_Ala951del	disruptive_inframe_deletion					28	0.0
-	MSH2(4.6%)	exon2,c.212-5_212-4del	0.046	0.056	637|59	109|11	0.03109	2213|71	2	47635523	47635525	CTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified		48	0.0
-	MSH2(18.9%)	exon2,c.212-4del	0.189	0.163	637|226	109|27	0.18610	2213|506	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		45	0.0
-	MSH2(7.2%)	exon2,c.212-4dup	0.072	0.064	637|94	109|14	0.11267	2213|281	2	47635523	47635525	CTT	CTTT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer		44	0.0
-	MSH2(1.0%)	exon2,c.212-4T>A	0.01	0.006066	1200|18	194|2	0.01519	3826|59	2	47635536	47635536	T	A	background	MSH2	NM_000251.3	1	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms		45	0.0
	MSH6(1.2%)	exon4,c.940A>G,p.S314G	0.012	0.011	627|9	112|0	0.00901	990|9	2	48026062	48026062	A	G	background	MSH6	NM_000179.3	4	c.940A>G	p.Ser314Gly	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		30	0.0
-	MSH6(6.3%)	exon5,c.3261del,p.F1088fs	0.063	0.053	3185|263	564|36	0.05049	8726|464	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		39	0.0
	RGPD3(20.4%)	exon16,c.2297A>G,p.N766S	0.204	0.001127	5421|1272	1271|0	0.18348	12038|2705	2	107049650	107049650	T	C	PASS	RGPD3	NM_001144013.2	16	c.2297A>G	p.Asn766Ser	missense_variant					45	0.0
	LRP1B(30.3%)	exon39,c.6226G>A,p.E2076K	0.303	0.002066	1323|570	627|0	0.32519	2154|1038	2	141459786	141459786	C	T	PASS	LRP1B	NM_018557.3	39	c.6226G>A	p.Glu2076Lys	missense_variant				COSV67197518	37	0.0
	LRP1B(14.1%)	exon29,c.4851G>T,p.E1617D	0.141	0.002864	1457|232	456|1	0.13146	2253|341	2	141607759	141607759	C	A	PASS	LRP1B	NM_018557.3	29	c.4851G>T	p.Glu1617Asp	missense_variant					44	0.0
	ERBB4(32.9%)	exon27,c.3275C>A,p.P1092H	0.329	0.00821	509|250	153|0	0.33302	709|354	2	212251784	212251784	G	T	PASS	ERBB4	NM_005235.3	27	c.3275C>A	p.Pro1092His	missense_variant				COSV104654088	37	0.0
	UGT1A1(1.3%)	exon,c.-55_-54insAT	0.013	0.02	4513|72	971|24	0.01107	19033|213	2	234668879	234668881	CAT	CATAT	clustered_events,multiallelic,normal_artifact,suspected_bg,chemotherapy_site	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(7)|_Uncertain_significance(1)|_Benign(3)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided		47	0.0
2	FANCD2(5.1%)	exon6,c.378-5del	0.051	0.085	1178|84	282|30	0.06559	2137|150	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	5	c.378-5del		splice_region_variant&intron_variant					48	0.0
2	FANCD2(4.1%)	exon6,c.378-5dup	0.041	0.033	1178|73	282|9	0.05484	2137|124	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	5	c.378-5dup		splice_region_variant&intron_variant					41	0.0
	TGFBR2(12.9%)	exon4,c.458del,p.K153fs	0.129	0.105	841|152	166|23	0.10616	1726|205	3	30691871	30691872	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided		40	0.0
	ANO10(4.5%)	exon2,c.132del,p.D45fs	0.045	0.042	2503|145	755|36	0.04103	5703|244	3	43647212	43647213	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		43	0.0
	ANO10(1.6%)	exon2,c.132dup,p.D45fs	0.016	0.023	2503|66	755|23	0.03093	5703|182	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Autosomal_recessive_spinocerebellar_ataxia_10|Autosomal_recessive_cerebellar_ataxia|not_provided		45	0.0
	MITF(21.9%)	exon8,c.789C>T,p.R263=	0.219	0.072	81|21	15|0	0.24324	84|27	3	70008502	70008502	C	T	PASS	MITF	NM_000248.4	8	c.789C>T	p.Arg263=	synonymous_variant				COSV58831871	22	0.0
	ATR(6.6%)	exon10,c.2320del,p.I774fs	0.066	0.049	4383|375	1567|107	0.06012	12115|775	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided		44	0.0
	ATR(1.5%)	exon10,c.2320dup,p.I774fs	0.015	0.02	4383|124	1567|52	0.03712	12115|467	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided		42	0.0
	IL7R(1.4%)	exon6,c.799del,p.R267fs	0.014	0.013	1147|21	238|3	0.01560	1956|31	5	35874636	35874637	GA	G	suspected_bg	IL7R	NM_002185.5	6	c.799del	p.Arg267fs	frameshift_variant&splice_region_variant					27	0.0
	MAP3K1(1.9%)	exon7,c.1346G>A,p.G449D	0.019	0.021	379|6	121|2	0.01285	461|6	5	56167781	56167781	G	A	normal_artifact,distinguished	MAP3K1	NM_005921.2	7	c.1346G>A	p.Gly449Asp	missense_variant				COSV105935479	21	0.0
	MSH3(1.2%)	exon7,c.1148del,p.K383fs	0.012	0.013	3988|68	1279|21	0.01640	9415|157	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided		38	0.0
	MSH3(1.3%)	exon7,c.1148dup,p.N385fs	0.013	0.014	3988|70	1279|27	0.01640	9415|157	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided		37	0.0
-	APC(20.1%)	exon5,c.423-4del	0.201	0.226	419|128	126|48	0.17045	1061|218	5	112111309	112111310	TA	T	multiallelic,normal_artifact,distinguished	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided		37	0.0
-	APC(7.7%)	exon5,c.423-4dup	0.077	0.054	419|56	126|15	0.09932	1061|117	5	112111309	112111310	TA	TAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified		34	0.0
-	APC(78.0%)	exon16,c.4067C>G,p.S1356*	0.78	0.002187	438|1483	554|0	0.76899	815|2713	5	112175358	112175358	C	G	PASS	APC	NM_000038.6	16	c.4067C>G	p.Ser1356*	stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided		39	0.0
	RAD50(4.4%)	exon13,c.2165del,p.K722fs	0.044	0.052	2931|167	508|27	0.04639	6413|312	5	131931451	131931452	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome		46	0.0
	RAD50(1.8%)	exon13,c.2165dup,p.E723fs	0.018	0.017	2931|76	508|12	0.02434	6413|160	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		36	0.0
	NSD1(1.7%)	exon18,c.5816G>A,p.R1939H	0.017	0.024	364|6	46|0	0.01354	437|6	5	176707759	176707759	G	A	background	NSD1	NM_022455.5	18	c.5816G>A	p.Arg1939His	missense_variant				COSV61781844	44	0.0
-	ARID1B(0.6%)	exon4,c.2137-2A>T	0.006223	0.007392	1469|10	197|2	0.01054	2254|24	6	157256598	157256598	A	T	background,low_allele_frac	ARID1B	NM_001374828.1	3	c.2137-2A>T		splice_acceptor_variant&intron_variant					40	0.0
1	EGFR(0.1%)	exon20,c.2375T>A,p.L792H	0.001193	0.004947	2470|4	277|1	0.00392	4320|17	7	55249077	55249077	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2375T>A	p.Leu792His	missense_variant				COSV51832111	24	0.0
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.001109	0.002935	3848|15	484|0	0.00469	7424|35	7	55259515	55259515	T	G	base_qual,clustered_events,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy		16	0.0
	GRM3(33.0%)	exon4,c.1835G>A,p.R612Q	0.33	0.006741	1563|771	432|1	0.34583	2304|1218	7	86468665	86468665	G	A	PASS	GRM3	NM_000840.3	4	c.1835G>A	p.Arg612Gln	missense_variant				COSV64471248	40	0.0
	ABCB1(0.3%)	exon13,c.1252C>T,p.Q418*	0.002931	0.002296	3243|10	867|1	0.00310	10285|32	7	87179585	87179585	G	A	low_allele_frac,chemotherapy_site	ABCB1	NM_000927.5	13	c.1252C>T	p.Gln418*	stop_gained					25	0.0
	KMT2C(1.6%)	exon53,c.14018G>A,p.R4673H	0.016	0.021	420|7	59|0	0.01908	514|10	7	151843697	151843697	C	T	background	KMT2C	NM_170606.3	53	c.14018G>A	p.Arg4673His	missense_variant				COSV105859081	38	0.0
-	KMT2C(2.0%)	exon38,c.8390dup,p.E2798fs	0.02	0.027	9137|240	2447|74	0.03209	30825|1022	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		37	0.0
	KMT2C(1.4%)	exon34,c.5068A>C,p.R1690=	0.014	0.017	400|5	71|0	0.05199	547|30	7	151882657	151882657	T	G	background	KMT2C	NM_170606.3	34	c.5068A>C	p.Arg1690=	synonymous_variant				COSV51275030	33	0.0
	KMT2C(2.4%)	exon14,c.2185_2189delinsGATTA,p.N729_S730>DY	0.024	0.033	516|10	99|2	0.01395	636|9	7	151945330	151945334	GAATT	TAATC	haplotype,normal_artifact	KMT2C	NM_170606.3	14	c.2185_2189delinsGATTA	p.Asn729_Ser730delinsAspTyr	missense_variant					31	0.0
	RUNX1T1(1.5%)	exon6,c.685C>T,p.R229*	0.015	0.015	446|6	79|0	0.00993	598|6	8	93004062	93004062	G	A	PASS	RUNX1T1	NM_175635.3	6	c.685C>T	p.Arg229*	stop_gained				COSV56147139	54	0.0
	IFITM3(8.1%)	exon1,c.208C>A,p.P70T	0.081	0.077	123|9	16|0	0.09945	163|18	11	320606	320606	G	T	background	IFITM3	NM_021034.3	1	c.208C>A	p.Pro70Thr	missense_variant				COSV67706711	38	0.0
	IFITM3(8.8%)	exon1,c.165C>T,p.P55=	0.088	0.078	126|10	16|0	0.12849	156|23	11	320649	320649	G	A	background	IFITM3	NM_021034.3	1	c.165C>T	p.Pro55=	synonymous_variant				COSV67706701	54	0.0
-	ATM(7.1%)	exon6,c.497-5_497-4del	0.071	0.042	105|14	39|2	0.05184	439|24	11	108114661	108114663	ATT	A	germline,multiallelic,normal_artifact	ATM	NM_000051.4	5	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		38	0.0
-	ATM(22.9%)	exon6,c.497-4del	0.229	0.249	105|46	39|15	0.20182	439|111	11	108114661	108114663	ATT	AT	germline,multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided		34	0.0
-	ATM(11.3%)	exon6,c.497-4dup	0.113	0.091	105|27	39|5	0.12897	439|65	11	108114661	108114663	ATT	ATTT	germline,multiallelic,normal_artifact,background	ATM	NM_000051.4	5	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		34	0.0
-	ATM(2.0%)	exon6,c.497-1G>T	0.02	0.032	289|16	87|4	0.05395	754|43	11	108114679	108114679	G	T	base_qual,normal_artifact,orientation,background	ATM	NM_000051.4	5	c.497-1G>T		splice_acceptor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(2)|_Uncertain_significance(1)	Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome		19	0.0
	ATM(1.1%)	exon14,c.2150G>A,p.R717Q	0.011	0.01	516|6	134|0	0.00888	670|6	11	108126967	108126967	G	A	PASS	ATM	NM_000051.4	14	c.2150G>A	p.Arg717Gln	missense_variant	Uncertain_significance		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		42	0.0
	CD3G(4.7%)	exon3,c.213del,p.K71fs	0.047	0.046	1617|91	243|13	0.04577	3023|145	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,background	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Combined_immunodeficiency_due_to_CD3gamma_deficiency		43	0.0
	CD3G(1.9%)	exon3,c.213dup,p.W72fs	0.019	0.017	1617|46	243|3	0.02389	3023|74	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Combined_immunodeficiency_due_to_CD3gamma_deficiency		37	0.0
	KMT2A(1.4%)	exon3,c.2318del,p.P773fs	0.014	0.011	5942|133	1061|14	0.01322	14933|200	11	118344185	118344186	AC	A	haplotype,normal_artifact,background	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Wiedemann-Steiner_syndrome|Inborn_genetic_diseases		45	0.0
	KRAS(0.2%)	exon2,c.53C>T,p.A18V	0.001778	0.003927	8764|17	3463|14	0.00238	30975|74	12	25398266	25398266	G	A	clustered_events,normal_artifact,low_allele_frac	KRAS	NM_033360.4	2	c.53C>T	p.Ala18Val	missense_variant	Pathogenic		Noonan_syndrome_3		35	0.0
	KMT2D(0.4%)	exon11,c.1367_1420del,p.S456_E473del	0.003683	0.007767	1794|7	242|1	0.00286	697|2	12	49446045	49446099	AATTCCTCAGGTGGTGGTGACAGGCGTGATGCCTCAGGTGGTGGGGACGTGGGTG	A	low_allele_frac	KMT2D	NM_003482.4	11	c.1367_1420del	p.Ser456_Glu473del	disruptive_inframe_deletion					31	0.0
-	BRCA2(1.4%)	exon23,c.9097dup,p.T3033fs	0.014	0.016	3675|63	882|17	0.01476	7609|114	13	32954022	32954022	C	CA	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided		39	0.0
	NBEA(0.7%)	exon22,c.3362del,p.N1121fs	0.007494	0.019	4224|46	1205|26	0.01155	8556|100	13	35733662	35733663	TA	T	multiallelic,normal_artifact,slippage,suspected_bg,low_allele_frac	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		32	0.0
	NBEA(0.8%)	exon22,c.3362dup,p.N1121fs	0.007643	0.017	4224|52	1205|29	0.01394	8556|121	13	35733662	35733663	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg,low_allele_frac	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		39	0.0
-	RB1(2.1%)	exon7,c.608-4del	0.021	0.027	8216|256	3037|111	0.02754	36825|1043	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided		41	0.0
-	RB1(3.0%)	exon7,c.608-4dup	0.03	0.043	8216|329	3037|172	0.04601	36825|1776	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome		41	0.0
-	RB1(0.2%)	exon7,c.608-3C>T	0.002364	0.002587	9472|22	3574|10	0.00457	42913|197	13	48934150	48934150	C	T	normal_artifact,low_allele_frac	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant					53	0.0
	BLM(1.8%)	exon7,c.1544del,p.N515fs	0.018	0.026	3593|95	817|30	0.02298	7865|185	15	91304138	91304139	GA	G	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome		40	0.0
	BLM(1.7%)	exon7,c.1544dup,p.N515fs	0.017	0.025	3593|91	817|25	0.02480	7865|200	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome		37	0.0
	CHD2(3.6%)	exon29,c.3734del,p.K1245fs	0.036	0.038	1011|52	224|12	0.03777	1707|67	15	93540315	93540316	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_specified|not_provided		38	0.0
	CHD2(3.6%)	exon29,c.3734dup	0.036	0.023	1011|47	224|4	0.04903	1707|88	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94		42	0.0
	CHD2(4.3%)	exon33,c.4173dup,p.Q1392fs	0.043	0.015	366|15	64|0	0.04319	576|26	15	93545433	93545433	G	GA	slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Pathogenic		CHD2-Related_Disorder|Autistic_behavior|Seizure|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided		29	0.0
	IGF1R(14.3%)	exon13,c.2775G>A,p.Q925=	0.143	0.167	25|4	5|0	0.12903	27|4	15	99467906	99467906	G	A	PASS	IGF1R	NM_000875.5	13	c.2775G>A	p.Gln925=	synonymous_variant					43	0.0
	FANCA(29.6%)	exon14,c.1235C>T,p.A412V	0.296	0.043	145|62	29|0	0.30435	160|70	16	89857935	89857935	G	A	Germline	FANCA	NM_000135.4	14	c.1235C>T	p.Ala412Val	missense_variant	Benign/Likely_benign		Fanconi_anemia_complementation_group_A|Fanconi_anemia|not_specified|not_provided		38	0.0
	TP53(75.4%)	exon8,c.844C>T,p.R282W	0.754	0.002427	1132|3510	978|2	0.75790	2827|8850	17	7577094	7577094	G	A	PASS	TP53	NM_000546.6	8	c.844C>T	p.Arg282Trp	missense_variant	Pathogenic/Likely_pathogenic		Li-Fraumeni_syndrome_1|Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Pleomorphic_xanthoastrocytoma|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Colorectal_cancer|Ovarian_serous_cystadenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Astrocytoma,_anaplastic|Glioblastoma|Li-Fraumeni_syndrome|Malignant_neoplasm_of_body_of_uterus|Li-Fraumeni-like_syndrome|not_provided		38	0.0
-	NF1(1.5%)	exon2,c.61-4del	0.015	0.022	1123|29	209|7	0.01724	2166|38	17	29482988	29482989	CT	C	normal_artifact,slippage,weak_evidence,suspected_bg	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided		39	0.0
	KRTAP4-7(7.7%)	exon1,c.321C>A,p.P107=	0.077	0.167	72|5	6|0	0.06195	106|7	17	39240779	39240779	C	A	haplotype,background	KRTAP4-7	NM_033061.3	1	c.321C>A	p.Pro107=	synonymous_variant				COSV66951092	22	0.0
	KRTAP4-7(8.2%)	exon1,c.333C>T,p.R111=	0.082	0.159	66|5	7|0	0.03846	100|4	17	39240791	39240791	C	T	haplotype,orientation,background	KRTAP4-7	NM_033061.3	1	c.333C>T	p.Arg111=	synonymous_variant				COSV66951122	10	0.0
-	BRCA1(1.2%)	exon10,c.1961dup,p.Y655fs	0.012	0.005804	1627|26	201|0	0.01183	2672|32	17	41245586	41245586	C	CT	slippage,weak_evidence,suspected_bg	BRCA1	NM_007294.4	10	c.1961dup	p.Tyr655fs	frameshift_variant	Pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		40	0.0
	XYLT2(1.3%)	exon8,c.1584del,p.G529fs	0.013	0.013	1478|22	173|2	0.01119	2652|30	17	48433966	48433967	AC	A	suspected_bg	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondylo-ocular_syndrome		37	0.0
	GNA11(91.7%)	exon6,c.771C>T,p.T257=	0.917	0.143	6|67	5|0	0.92683	6|76	19	3119239	3119239	C	T	germline,Germline	GNA11	NM_002067.5	6	c.771C>T	p.Thr257=	synonymous_variant	Benign		not_specified|not_provided		46	0.0
	CIC(0.8%)	exon11,c.2821C>T,p.P941S	0.008329	0.045	751|7	48|1	0.00716	1110|8	19	42795832	42795832	C	T	normal_artifact	CIC	NM_015125.5	11	c.2821C>T	p.Pro941Ser	missense_variant					21	0.0
	NCOA3(3.8%)	exon20,c.3753_3765delinsA,p.Q1252_Q1255del	0.038	0.051	800|30	62|2	0.03771	1684|66	20	46279827	46279839	GCAGCAGCAACAG	A	clustered_events,haplotype,normal_artifact	NCOA3	NM_181659.3	20	c.3753_3765delinsA	p.Gln1252_Gln1255del	conservative_inframe_deletion&synonymous_variant					50	0.0
	ADNP(0.2%)	exon5,c.3047A>G,p.K1016R	0.001536	0.001925	12346|29	1437|3	0.02135	33687|735	20	49508204	49508204	T	C	low_allele_frac	ADNP	NM_015339.5	5	c.3047A>G	p.Lys1016Arg	missense_variant					43	0.0
	ERG(2.2%)	exon4,c.463G>A,p.V155I	0.022	0.02	270|5	69|0	0.01471	335|5	21	39775557	39775557	C	T	PASS	ERG	NM_182918.4	4	c.463G>A	p.Val155Ile	missense_variant				COSV55726607	29	0.0
	NEFH(35.0%)	exon4,c.1973_1977delinsCAGAA,p.E658A	0.35	0.159	32|20	5|0	0.25532	35|12	22	29885602	29885606	AAGAG	CAGAA	haplotype,orientation	NEFH	NM_021076.4	4	c.1973_1977delinsCAGAA	p.Glu658Ala	missense_variant					5	0.0
	CYP2D6(9.5%)	exon7,c.986G>T,p.R329L	0.095	0.088	226|19	34|3	0.07862	293|25	22	42523636	42523636	C	A	normal_artifact,chemotherapy_site	CYP2D6	NM_000106.6	7	c.986G>T	p.Arg329Leu	missense_variant&splice_region_variant				COSV62242939	12	0.0
	TAF1(0.8%)	exon27,c.4136G>A,p.R1379H	0.008302	0.018	1232|10	82|0	0.00755	1708|13	X	70627452	70627452	G	A	background	TAF1	NM_004606.5	27	c.4136G>A	p.Arg1379His	missense_variant				COSV99335857	37	0.0
